Discuss the significance of India's nationwide HPV vaccination campaign in the context of WHO's global strategy for cervical cancer elimination.

Q. Discuss the significance of India's nationwide HPV vaccination campaign in the context of WHO's global strategy for cervical cancer elimination. (15 marks, 250-350 words)

Cervical cancer is India's second most common cancer among women, with HPV types 16 and 18 causing over 80% of cases [2]. The nationwide HPV vaccination campaign launched on 28 February 2026 from Ajmer, Rajasthan, is therefore both a public health milestone and India's most direct contribution yet to WHO's cervical cancer elimination goal.

Alignment with WHO's 90-70-90 strategy - WHO's 2020 global strategy — the first to target elimination of a cancer as a public health problem — sets 90-70-90 targets by 2030: 90% of girls vaccinated by age 15, 70% of women screened, 90% of those detected treated [3]. - India's campaign targets girls who have completed 14 but not 15 years, addressing the first pillar precisely within WHO's age window [2]. - Linking vaccination with screening and early diagnosis at Ayushman Arogya Mandirs and treatment at Day Care Cancer Centres covers the screening and treatment pillars, giving a continuum-of-care design rather than a single intervention [1]. - India joins 160 of 194 WHO member states with HPV vaccine in national schedules, and its single-dose Gardasil-4 regimen mirrors the shift by about 90 countries towards cost-effective single-dose schedules [2].

Significance for India's health governance - Scale: ~1.2 crore girls annually across all 36 States/UTs; over 52 lakh vaccinated by mid-July 2026 [1]. - Equity: free and voluntary with parental consent, with focused outreach to rural, tribal and urban slum populations [1][2]. - Institutional strength: validation by NTAGI, real-time monitoring through the U-WIN platform, and staff training completed in all States/UTs — evidence of working Centre-State coordination [1][2].

By embedding a cancer-prevention vaccine within the Universal Immunization Programme and Ayushman Bharat infrastructure, India has converted a global target into deliverable routine practice. Sustaining coverage beyond the campaign phase, countering vaccine hesitancy and scaling adult screening remain the tasks ahead. Done well, this advances both SDG 3 and the constitutional promise of health equity under Article 21.

(~305 words)

Sources: 1. Update on HPV Vaccination Programme and Cervical Cancer Prevention, Ministry of Health and Family Welfare, PIB (21 July 2026) — coverage figures, delivery points, U-WIN tracking, staff training, screening-to-treatment continuum 2. Prime Minister Shri Narendra Modi Launches Nationwide HPV Vaccination Drive for 14-Year-Old Girls from Ajmer, Rajasthan, PIB — launch date and place, Gardasil-4 single dose, target age group, NTAGI validation, global adoption figures, disease burden 3. Global strategy to accelerate the elimination of cervical cancer as a public health problem, WHO (2020) — 90-70-90 targets by 2030